Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2007
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852431A1 Optically active tetrahydronaphthalene derivative
11/07/2007EP1852420A1 Indole compound and use thereof
11/07/2007EP1400521B1 Piperazine compounds
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1276473B1 Pharmaceutical formulations for dry powder inhalers
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
11/07/2007CN101068826A Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11/07/2007CN101068817A Novel thienopyridinepyrimidine derivatives
11/07/2007CN101068816A Novel thienopyridinepyrimidine derivatives
11/07/2007CN101068798A Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066465A Antitumor use of antisense thionucleotide
11/07/2007CN101066441A Heat clearing white peony bolus
11/07/2007CN101066440A Shensu Qi-benefiting decoction
11/07/2007CN101066403A New process of preparing fresh snow prepn
11/07/2007CN101066394A Externally applied medicine for treating infantile pneumonitis, bronchitis and asthma
11/07/2007CN101066359A Medicine for treating tuberculosis and its prepn
11/07/2007CN101066343A Externally applied Chinese medicine for treating tonisillitis and lymphnoditis and its prepn process
11/07/2007CN101066302A Phlegm eliminating and indigestion relieving whiteflower hogfennel bolus
11/07/2007CN101066295A Recipe and prepn process of oral olive liquid
11/07/2007CN101066159A Tar-reducing and toxin-decrasing cigarette and its production process
11/07/2007CN100347293C Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/07/2007CN100347193C Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347151C Novel aminobenzoephenones
11/07/2007CN100346831C Combination of a PDE inhibitor and a leukotriene receptor antagonist
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346820C Jindilan detoxin medicinal composition, preparation and its preparation method
11/07/2007CN100346809C Mint oil adding method in production of Chinese medicine 'pinellia dew tablet'
11/07/2007CN100346792C Benzothiazole derivatives as adenosine receptor ligands
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346777C New synergistic combination comprising roflumilast and formoterol
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291625 Administering a combination of nicotinic acid or nicotinamide and riboflavin to treat urticaria, asthma, allergic rhinitis, and allergic oculorhinitis
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2451519C Tablet comprising cetirizine and pseudoephedrine
11/06/2007CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
11/06/2007CA2363713C Lantibiotic
11/06/2007CA2267322C Pde iv inhibiting 2-cyanoiminoimidazole derivatives
11/04/2007CA2587126A1 Method of treating inflammation disorders using extracts of passion fruit
11/01/2007WO2007124447A2 Use of chalcogenides for treating shock and other adverse conditions
11/01/2007WO2007124322A1 Inhibitors of c-fms kinase
11/01/2007WO2007124321A1 Inhibitors of c-fms kinase
11/01/2007WO2007124319A1 Inhibitors of c-fms kinase
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007123465A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder
11/01/2007WO2007122981A1 COUMARIN COMPOUND CAPABLE OF INHIBITING INDUCIBLE NITROGEN MONOOXIDE SYNTHASE (iNOS)
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007121923A1 Purine derivatives as a2a receptor agonists
11/01/2007WO2007121921A2 Purine derivatives for use as adenosin a2a receptor agonists
11/01/2007WO2007106022A3 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
11/01/2007WO2007096151A3 Inhibitors of p38-kinase for treatment of pulmonary hypertension
11/01/2007WO2007077510A3 Muscarinic receptor antagonists
11/01/2007WO2007075858A3 Novel forms of tiotropium bromide and processes for preparation thereof
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007059905A9 Thienopyrimidines treating inflammatory diseases
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070254928 Use of Roflumilast for the Prophylaxis or Treatment of Emphysema
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254873 Chemical Compounds
11/01/2007US20070254857 2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
11/01/2007US20070254838 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
11/01/2007CA2650057A1 Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase
11/01/2007CA2650033A1 Compositions and methods useful for treatment of respiratory illness
11/01/2007CA2649924A1 Inhibitors of c-fms kinase
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649739A1 Inhibitors of c-fms kinase
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007CA2648813A1 Organic compounds
11/01/2007CA2648741A1 Purine derivatives as a2a receptor agonists
11/01/2007CA2646674A1 Use of chalcogenides for treating shock and other adverse conditions
10/2007
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1849468A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848436A2 Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association
10/31/2007EP1755606B1 Quinazolinone derivatives useful as vanilloid antagonists
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1448198B1 Nicotin-or isonicotin benzothiazole derivatives
10/31/2007EP1368301B1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007DE102006019589A1 Inhibitoren des TASK-1 und Task-3 Ionenkanals Inhibitors of the TASK-1 and Task 3 ion channel
10/31/2007CN101065382A Substituted pteridines for treating inflammatory diseases
10/31/2007CN101065370A 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 878